Nanox to Report Second Quarter 2026 Financial Results on September 9, 2026
Rhea-AI Summary
Nanox (Nasdaq: NNOX) announced it will release its financial results for the quarter ended June 30, 2026 before market open on Monday, September 9, 2026. Following the release, CEO and Acting Chairman Erez Meltzer and CFO Guy Nathanzon will host a conference call and live webcast at 8:30 a.m. ET, with access details and webcast link available via online registration and the Investor Relations section of the Nanox website under Events and Presentations.
Positive
- None.
Negative
- None.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jun 11 | earnings date | Neutral | +2.9% | Scheduled Q1 2026 results and an 8:30 a.m. ET conference call. |
| Apr 06 | earnings date | Neutral | -3.0% | Scheduled Q4 2025 results and management's 8:30 a.m. ET conference call. |
| Nov 07 | earnings date | Neutral | -1.6% | Scheduled Q3 2025 results and an 8:30 a.m. ET conference call. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Earnings-date announcements produced mixed 24-hour reactions, with two negative moves and one positive move.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PETACH TIKVA, Israel, Aug. 25, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended June 30, 2026, before market open on Monday, September, 9, 2026. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Guy Nathanzon, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET.
Interested parties may register for the conference call using the following link: Nanox Q2 2026 Conference Call
The live webcast of the conference call may be accessed by using the following link: Nanox Q2 2026 Webcast
The webcast link will also be posted in the Investor Relations section of the Nanox website at Events and Presentations.
About Nanox
Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform.
Nanox combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care.
Nanox’s vision is to expand the reach of medical imaging both within and beyond traditional hospital settings by providing a seamless solution from scan to interpretation and beyond. By leveraging proprietary digital X-ray technology, AI-driven analytics, and a clinically driven approach, Nanox aims to enhance the efficiency of routine imaging workflows, support early detection of disease, and improve patient outcomes.
The Nanox ecosystem includes Nanox.ARC, a cost-effective, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability; Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery.
By integrating imaging technology, AI, cloud infrastructure, clinical expertise, a marketplace, and health information technology, Nanox seeks to lower barriers to adoption, improve utilization, and advance preventive care worldwide. For more information, please visit www.nanox.vision
Contacts
Investor Contact
Mike Cavanaugh
ICR Healthcare
mike.cavanaugh@icrhealthcare.com
Media Contact
ICR Healthcare
NanoxPR@icrinc.com